Erratum For: Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells
Cellular Physiology and Biochemistry - Switzerland
doi 10.33594/000000135
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 24, 2019
Authors
Unknown
Publisher
Cell Physiol Biochem Press GmbH and Co KG